CervoMed (CRVO) Asset Utilization Ratio (2011 - 2026)
CervoMed (CRVO) posted Asset Utilization Ratio of 0.11 for Q1 2026, down 26.59% sequentially from 0.15 in Q4 2025, and down 51.76% YoY from 0.23 in Q1 2025.
CervoMed (CRVO) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
CervoMed has reported Asset Utilization Ratio for 9 years, with the latest figure at 0.11 in Q1 2026.
- Quarterly Asset Utilization Ratio fell 51.76% year-over-year to 0.11 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.11 (down 51.76% YoY) and the FY2025 annual result came in at 0.12, down 66.91% from the prior year.
- Asset Utilization Ratio declined to 0.11 in Q1 2026 per CRVO's latest filing, from 0.15 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.9 in Q1 2024 and troughed at 0.0 in Q3 2022.
- A 5-year average of 0.35 and a median of 0.22 in 2024 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio surged 23304.64% in 2023, then tumbled 74.66% in 2025.
- Over 5 years, Asset Utilization Ratio stood at 0.0 in 2022, then soared by 25041.68% to 0.65 in 2023, then slumped by 67.38% to 0.21 in 2024, then decreased by 29.26% to 0.15 in 2025, then retreated by 26.59% to 0.11 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.11, 0.15, and 0.18 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - | 0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.02 |
| Mar 31, 2026 | 0.11 |
| Dec 31, 2025 | 0.15 |
| Sep 30, 2025 | 0.18 |
| Jun 30, 2025 | 0.20 |
| Mar 31, 2025 | 0.23 |
| Dec 31, 2024 | 0.21 |
| Sep 30, 2024 | 0.20 |
| Jun 30, 2024 | 0.32 |
| Mar 31, 2024 | 0.90 |
| Dec 31, 2023 | 0.65 |
| Sep 30, 2023 | 0.60 |
| Jun 30, 2023 | 0.86 |
| Mar 31, 2023 | 0.35 |
| Sep 30, 2022 | 0.00 |
| Mar 31, 2014 | 0.00 |
| Sep 30, 2013 | 0.04 |
| Jun 30, 2013 | 0.23 |
| Mar 31, 2013 | 0.14 |
| Dec 31, 2012 | 0.36 |